What is Intervention Insights?
Operating as a key subsidiary of NeoGenomics Bioinformatics, Intervention Insights—through its flagship platform Trapelo—addresses the critical friction points within the cancer care ecosystem. By integrating real-time, evidence-based data, the company facilitates seamless communication between oncologists, diagnostic laboratories, and healthcare payers. This information technology infrastructure is designed to mitigate the challenges posed by the rapid evolution of genomic science, ensuring that clinical decision-making is both transparent and data-driven. The platform serves as a vital bridge in the precision medicine value chain, optimizing patient outcomes while streamlining administrative and clinical workflows.
How much funding has Intervention Insights raised?
Intervention Insights has raised a total of $11.4M across 2 funding rounds:
Series B
$7.2M
Private Equity
$4.2M
Series B (2011): $7.2M, investors not publicly disclosed
Private Equity (2017): $4.2M, investors not publicly disclosed
Key Investors in Intervention Insights
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Intervention Insights?
With the recent capital deployment, Intervention Insights is positioned to scale its technological infrastructure and expand its footprint within the precision medicine sector. The company is expected to leverage these resources to enhance its evidence-based decision support tools, potentially integrating more advanced diagnostic analytics to meet the increasing demand for personalized cancer care. As the industry shifts toward value-based reimbursement models, the firm's focus on transparency and real-time data will likely serve as a competitive moat. Future growth strategies will likely prioritize the expansion of its media platform, The Precision Medicine Podcast, to further influence industry standards and solidify its role as a thought leader in the oncology technology space.
See full Intervention Insights company page
